| D002561 |
Cerebrovascular Disorders |
A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. |
Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial |
|
| D004877 |
Ergoloid Mesylates |
A mixture of the mesylates (methane sulfonates) of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly. |
Co-Dergocrine Mesylate,Dihydroergotoxine Mesylate,Circanol,Co-Dergine Mesylate,Co-Dergocrine Mesilate,Dihydroergotoxine Methanesulfonate,Dihydroergotoxine Monomethanesulfonate,Ergodesit,Ergoloid Mesylate,Ergotoxin, Dihydro-, Monomethasulfonate,Hydergine,Redergam,Redergin,Redergine,Co Dergine Mesylate,Co Dergocrine Mesilate,Co Dergocrine Mesylate,Methanesulfonate, Dihydroergotoxine,Monomethanesulfonate, Dihydroergotoxine |
|